You are here

PCR Sales Soared in Wuhan Before 1st Official COVID-19 Cases Publicized - Report

PCR Sales Soared in Wuhan Before 1st Official COVID-19 Cases Publicized - Report | 5 Oct 2021 | Spending on tests to detect the novel coronavirus soared in Wuhan, China, several months before the first official reporting of COVID-19 cases, suggesting the virus was already circulating in communities during the northern summer in 2019 before it was made public by Beijing, according to research by Australian cybersecurity firm Internet 2.0. The firm tracked the sales of polymerase chain reaction (PCR) tests over several years, revealing an almost 50 percent increase between 2018 to 2019 -- the year before the COVID-19 outbreak spread across the world. Sales of PCR tests, used to detect specific viruses, totaled 19.1 million yuan (AU$4 million) in 2016, before rising to 29.1 million yuan (AU$6 million) in 2017, 36.7 million yuan in 2018, and 67.4 million yuan (AU$14 million) in 2019.